Maciej Stanczyk

62 Pabianicka St
Lodz, LD 93513, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Synthetic routes to nanoconjugates of anthracyclines.

Synthetic routes to nanoconjugates of anthracyclines.

Journal: Bioorganic chemistry
Published: August 19, 2019

Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody.

Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody.

Journal: Polymers
Published: July 31, 2019

Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy.

Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy.

Journal: Pharmaceutical research
Published: March 26, 2019

Sugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells - Possible Role of GLUT1 Transporter.

Sugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells - Possible Role of GLUT1 Transporter.

Journal: Pharmaceutical research
Published: March 25, 2019

Synthetic routes to nanomaterials containing anthracyclines: noncovalent systems.

Synthetic routes to nanomaterials containing anthracyclines: noncovalent systems.

Journal: Biomaterials science
Published: August 25, 2018

Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody-Trastuzumab: The New Approach of a Well-Known Strategy.

Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody-Trastuzumab: The New Approach of a Well-Known Strategy.

Journal: Polymers
Published: January 18, 2018

Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS).

Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS).

Journal: Materials (Basel, Switzerland)
Published: April 12, 2017

Trastuzumab - a monoclonal antibody - and dendrimers in a targeted therapy for breast cancer

Trastuzumab - a monoclonal antibody - and dendrimers in a targeted therapy for breast cancer

Journal: Postepy higieny i medycyny doswiadczalnej (Online)
Published: December 17, 2015
Showing 1-8 of 8

Last Updated: 09/26/2026